SCHEMBL20101403

SCHEMBL20101403

COc1ccc(C(OCc2ccc3c(c2)OCc2cc(OO)ccc2-3)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 10/20 0.41
MAOB P27338 3/20 0.38
MAOA P21397 2/20 0.38
AKR1B1 P15121 1/20 0.38
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
ALOX12 P18054 1/20 0.37
RAB9A P51151 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
POLB P06746 1/20 0.36
MAPK14 Q16539 1/20 0.36
ROCK1 Q13464 1/20 0.36
SLC6A1 P30531 2/20 0.36
SLC6A11 P48066 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16624700 0.90 ROCK2 (0.41) ROCK2MAOBMAOAAKR1B1MAPT
SCHEMBL16624617 0.86 MAOB (0.44) ROCK2MAOBMAOAMAPTSMN1; SMN2
SCHEMBL16624706 0.86 ROCK2 (0.48) ROCK2MAPTSMN1; SMN2POLBROCK1
SCHEMBL16624701 0.85 ROCK2 (0.38) ROCK2MAOBMAOAROCK1
SCHEMBL16624802 0.84 ROCK2 (0.41) ROCK2AKR1B1MAPTSMN1; SMN2POLB
SCHEMBL16624715 0.83 ROCK2 (0.46) ROCK2MAOBMAOASMN1; SMN2KDM4E
SCHEMBL16624702 0.82 ROCK2 (0.46) ROCK2SMN1; SMN2RAB9AROCK1
SCHEMBL18165313 0.81 SMPD1 (0.43) ROCK2MAOBMAOASMN1; SMN2RAB9A
SCHEMBL16624619 0.81 MAOA (0.41) ROCK2MAOBMAOASMN1; SMN2RAB9A
SCHEMBL16624806 0.80 ROCK2 (0.38) ROCK2AKR1B1MAPTSMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052107-B1 ORGANIC COMPOUNDS TO TREAT HEPATITIS B VIRUS NOVARTIS AG (CH) 2018-05-02 EP disclosed